相关实验视频

Updated: Jun 19, 2025

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

来自5-烯和[b]的化合物:杀死结核菌菌并减少其毒性

Hong-Mei Dong¹, Jun-Xian Chen¹, Yu-Xiang Cai¹

¹College of Pharmacy, Guizhou University, Jiaxiu South Road, Guiyang, 550025, China.

Chemistry & biodiversity

|July 26, 2024

概括

一种新型化合物,1-([b]thiophen-2-ylmethylene) thiosemicarbazide,可以有效地抑制Mycobacterium结核病催化酶 (KatG),这是一个关键的毒性因子. 这种化合物在动物模型中通过减少细菌负载和颗粒瘤大小来对抗耐药结核病具有前途.

科学领域:

药用化学医学化学
微生物学微生物学
药物发现药物发现药物发现

背景情况:

耐药性Mycobacterium结核病 (Mtb) 构成了重大的全球卫生挑战,需要新的治疗策略.
针对细菌毒性因子,如Mtb的催化酶 (KatG),是对抗耐药性的有希望的方法.
KatG对于Mtb的排毒至关重要,并有助于其致病性.

研究的目的:

合成和评估新型的5-氧和[b]衍生物作为潜在的抗菌剂.
确定针对Mtb KatG的抑制剂,作为克服耐药性的战略.
在结核病感染模型中评估最强效化合物的体内疗效.

主要方法:

合成了12种新型衍生物,这些衍生物来自5-烯和[b]二烯基支架.
确定抗菌细菌活性和最小抑制度 (MIC).
在体外评估KatG抑制,活性氧物种 (ROS) 生产和Mtb杀死动力学.
分子对接模拟以预测与Mtb-KatG.G.的结合亲和力.
在子皮肤结核病模型中评估化合物疗效.

主要成果:

十二种衍生品表现出抗菌菌活性,MICs范围从0.5到32μg/mL.
化合物2,1-([b]thiophen-2-ylmethylene) thiosemicarbazide,证明了对Mtb KatG的强烈抑制,并增强了ROS的产生.
化合物2在4×MIC下在96小时内实现了Mtb杀死,并且在体内显著减少了颗粒瘤大小和细菌负载.
分子对接证实了化合物2与Mtb-KatG活性部位的强烈结合.

结论:

化合物2是一种强大的Mtb KatG抑制剂,具有显著的抗菌活性.
这种化合物有效地降低了动物模型中的Mtb毒性和细菌负载.
化合物2代表了一种有希望的分子,用于开发针对毒性因素的新型抗结核药物.

关键词:

5 - - 氧氨基氨酸是什么?子[b]硫二烯的使用方法结核病菌菌菌的结核病菌的结核病菌.综合合成综合合成病毒性病毒性

更多相关视频

Visualization of the Charcoal Agar Resazurin Assay for Semi-quantitative, Medium-throughput Enumeration of Mycobacteria

Visualization of the Charcoal Agar Resazurin Assay for Semi-quantitative, Medium-throughput Enumeration of Mycobacteria

Published on: December 14, 2016

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments

Published on: October 25, 2024

相关概念视频

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

Combined Effects of Drugs: Synergism

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...

Electrophilic Aromatic Substitution: Fluorination and Iodination of Benzene

Electrophilic Aromatic Substitution: Fluorination and Iodination of Benzene

Bromination and chlorination of aromatic rings by electrophilic aromatic substitution reactions are easily achieved, but fluorination and iodination are difficult to achieve. Fluorine is so reactive that its reaction with benzene is difficult to control, resulting in poor yields of monofluoroaromatic products. To address this, Selectfluor reagent is used as a fluorine source in which a fluorine atom is bonded to a positively charged nitrogen.